// App-Quantinova.ai

1078 : Bioequivalent pharmacokinetics for generic and originator Hepatitis C Direct Acting Antivirals

Researchers

Presenter

  • Andrew M. Hill

Principal Investigators

  • Loai Tahat

  • Mohammed Khalil Mohammed

  • Sanjay Nath

  • Rabab Fayez Tayyem

  • James A. Freeman

  • Ismahane Benbitour

  • Sherine Helmy

Medical Centers

  • Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom

  • Pharmaceutical Research Unit, Amman, Jordan

  • ACDIMA BioCentre, Amman, Jordan

  • NCRI and Imperial College London, London, United Kingdom

  • GP2U Telehealth, Hobart, TAS, Australia

  • R&D Project Innovations, Pharco, Cairo, Egypt

  • BEKER Laboratories, Algiers, Algeria

Locations

  • United Kingdom

  • Jordan

  • Australia

  • Egypt

  • Algeria

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • daclatasvir

  • Sofosbuvir

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved